Effects of an Exercise Intervention on Taxane-induced Peripheral Neuropathy in Breast Cancer Survivors
Launched by TAICHUNG VETERANS GENERAL HOSPITAL · Nov 30, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
The incidence of breast cancer increases yearly. Taxane is one of the main chemotherapy drugs for breast cancer treatment. Taxane-induced peripheral neuropathy (TIPN) impairs breast cancer survivors' functioning, increases the risk of falls, and impacts quality of life (QOL). As TIPN worsens, there is a need to decrease chemotherapy dosage or terminate treatment. This may reduce the effect of chemotherapy, in addition, to increasing survivor's mortality. Up to date, no evidence-based, effective nonpharmacologic intervention to prevent or manage TIPN. Furthermore, no interventions were recom...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participants will be randomly allocated to the experimental or observational group using the two strata: (1) adjuvant or neoadjuvant and (2) paclitaxel, docetaxel, or Taxane plus Platinum.
- Exclusion Criteria:
- • Participants who have peripheral neuropathy before chemotherapy or regular exercise are excluded.
Trial Officials
Chih-Chiang Hung, Doctor
Principal Investigator
Taichung Veterans General Hospital
About Taichung Veterans General Hospital
Taichung Veterans General Hospital is a leading medical institution in Taiwan, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to facilitate the development of new therapies and improve patient outcomes. With a focus on patient-centered care and adherence to rigorous ethical standards, Taichung Veterans General Hospital plays a pivotal role in bridging the gap between research and clinical practice, fostering collaborations that contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials